The numbers, that were first published in 20 Minuten, were confirmed by the Federal Office of Public Health (FOPH) on Monday. In total, 362 fully vaccinated people were infected and 86 of them had to be hospitalised.
The FOPH believes that these numbers are probably an underestimate because many people who were infected despite being vaccinated have not been registered. Even if the real figure is probably higher, it is within the expected range, according to the FOPH.
It is not possible to determine how many of these 18 deaths in Switzerland are due to the Delta variant. The estimated proportion of new infections with the delta mutation is currently 96.7% in the seven-day average.
Still at risk
The vaccines administered in Switzerland – Moderna and Pfizer/Biontech – do not offer 100% protection. According to the manufacturer, the Pfizer/Biontech vaccine offers 88% protection against the Delta variant. A U.S. study suggests similar figures for Moderna’s vaccine. However, these figures are disputed: an Israeli study estimates that the protection offered by both vaccines is only around 65%.
Currently, a little over 4.8 million of 8.6 million Swiss residents have been fully vaccinated. If the 88% protection against the coronavirus claimed by the manufacturers is correct, more than 570,000 can potentially be reinfected despite receiving two doses of vaccine. The figure is triple if the Israeli study, citing an efficacy of 65%, is used as a reference.
The FOPH considers that two doses of messenger RNA vaccine offer good protection against the current variants of the virus. The health authorities are not currently planning a booster vaccination campaign but are monitoring the situation closely.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
This content was published on
The vast majority of Swiss people (73%) wants to get inoculated, according to survey results published by the German-language newspaper Schweiz am Wochenende. Fifteen percent remain undecided and 12% oppose vaccination – compared to 28% in November. “The willingness to be vaccinated is increasing rapidly,” says Marcel Zbinden, an occupational psychologist at the Lucerne University…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.